VANDA PHARMACEUTICALS INC
VNDA·921659108·US·Common Stock·Healthcare - Biotechnology-13D/G
VNDA (VANDA PHARMACEUTICALS INC) is held by 106 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($50.3M), RENAISSANCE TECHNOLOGIES LLC ($26M), STATE STREET CORP ($20.8M). Net institutional sentiment: Mixed.
106
Holders
Avg rating(24 Elite)
$260M
Total Value
64% (116)
Fund Consensus
70 buying - 39 selling
Who's Trading
ActivistBPBlackRock Portfolio Management LLC4.2%Apr 29, 2026
InsiderDCDuncan Charles CliffVest 57K shApr 22, 2026
InsiderPHPolymeropoulos Mihael HristosSell $1.3MMar 2, 2026
InsiderBGBirznieks GuntherSell $351KMar 2, 2026
InsiderMPMoran Kevin PatrickSell $351KMar 2, 2026
InsiderWTWilliams TimothySell $351KMar 2, 2026
InsiderWJWijkstrom JoakimSell $255KMar 2, 2026
InsiderHTHonore TageSell $241KFeb 23, 2026
13F: Insider & Congress:
Showing 1-20 of 116
1 / 6
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer